nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—TNK2—female gonad—uterine fibroid	0.00151	0.0019	CbGeAlD
Crizotinib—IGF1R—female gonad—uterine fibroid	0.00151	0.0019	CbGeAlD
Crizotinib—SLK—uterine cervix—uterine fibroid	0.00151	0.0019	CbGeAlD
Crizotinib—RPS6KB1—decidua—uterine fibroid	0.00151	0.0019	CbGeAlD
Crizotinib—IGF1R—vagina—uterine fibroid	0.0015	0.00189	CbGeAlD
Crizotinib—TYK2—urethra—uterine fibroid	0.0015	0.00189	CbGeAlD
Crizotinib—LCK—decidua—uterine fibroid	0.0015	0.00189	CbGeAlD
Crizotinib—FGR—decidua—uterine fibroid	0.0015	0.00189	CbGeAlD
Crizotinib—EPHA4—mammalian vulva—uterine fibroid	0.0015	0.00189	CbGeAlD
Crizotinib—EPHB4—uterine cervix—uterine fibroid	0.0015	0.00189	CbGeAlD
Crizotinib—AXL—decidua—uterine fibroid	0.00149	0.00188	CbGeAlD
Crizotinib—MAP4K2—female gonad—uterine fibroid	0.00149	0.00188	CbGeAlD
Crizotinib—TBK1—endometrium—uterine fibroid	0.00149	0.00187	CbGeAlD
Crizotinib—JAK2—uterine cervix—uterine fibroid	0.00149	0.00187	CbGeAlD
Crizotinib—LIMK2—female reproductive system—uterine fibroid	0.00149	0.00187	CbGeAlD
Crizotinib—RIPK2—cardiac atrium—uterine fibroid	0.00148	0.00187	CbGeAlD
Crizotinib—MAP4K2—vagina—uterine fibroid	0.00148	0.00187	CbGeAlD
Crizotinib—TYK2—endometrium—uterine fibroid	0.00148	0.00186	CbGeAlD
Crizotinib—STK3—female gonad—uterine fibroid	0.00147	0.00185	CbGeAlD
Crizotinib—TIE1—female gonad—uterine fibroid	0.00147	0.00185	CbGeAlD
Crizotinib—MAP3K12—female reproductive system—uterine fibroid	0.00147	0.00185	CbGeAlD
Crizotinib—ACVR1—female reproductive system—uterine fibroid	0.00147	0.00185	CbGeAlD
Crizotinib—FLT3—female reproductive system—uterine fibroid	0.00147	0.00185	CbGeAlD
Crizotinib—EPHA2—uterine cervix—uterine fibroid	0.00147	0.00185	CbGeAlD
Crizotinib—CSF1R—myometrium—uterine fibroid	0.00147	0.00185	CbGeAlD
Crizotinib—STK3—vagina—uterine fibroid	0.00146	0.00184	CbGeAlD
Crizotinib—EPHB4—smooth muscle tissue—uterine fibroid	0.00146	0.00183	CbGeAlD
Crizotinib—RPS6KB1—urethra—uterine fibroid	0.00145	0.00183	CbGeAlD
Crizotinib—FGR—urethra—uterine fibroid	0.00145	0.00182	CbGeAlD
Crizotinib—LCK—urethra—uterine fibroid	0.00145	0.00182	CbGeAlD
Crizotinib—JAK2—smooth muscle tissue—uterine fibroid	0.00145	0.00182	CbGeAlD
Crizotinib—STK35—female reproductive system—uterine fibroid	0.00144	0.00181	CbGeAlD
Crizotinib—AXL—urethra—uterine fibroid	0.00144	0.00181	CbGeAlD
Crizotinib—TBK1—mammalian vulva—uterine fibroid	0.00144	0.00181	CbGeAlD
Crizotinib—SLK—decidua—uterine fibroid	0.00144	0.00181	CbGeAlD
Crizotinib—EPHA4—cardiac atrium—uterine fibroid	0.00144	0.00181	CbGeAlD
Crizotinib—MAP3K3—uterine cervix—uterine fibroid	0.00143	0.00181	CbGeAlD
Crizotinib—MAP4K5—uterine cervix—uterine fibroid	0.00143	0.00181	CbGeAlD
Crizotinib—AURKA—female gonad—uterine fibroid	0.00143	0.0018	CbGeAlD
Crizotinib—RPS6KB1—endometrium—uterine fibroid	0.00143	0.0018	CbGeAlD
Crizotinib—TYK2—mammalian vulva—uterine fibroid	0.00143	0.0018	CbGeAlD
Crizotinib—EPHA4—uterus—uterine fibroid	0.00143	0.0018	CbGeAlD
Crizotinib—EPHB4—decidua—uterine fibroid	0.00143	0.0018	CbGeAlD
Crizotinib—AURKA—vagina—uterine fibroid	0.00142	0.00179	CbGeAlD
Crizotinib—FGR—endometrium—uterine fibroid	0.00142	0.00179	CbGeAlD
Crizotinib—TESK1—female gonad—uterine fibroid	0.00142	0.00179	CbGeAlD
Crizotinib—AXL—endometrium—uterine fibroid	0.00142	0.00178	CbGeAlD
Crizotinib—JAK2—decidua—uterine fibroid	0.00142	0.00178	CbGeAlD
Crizotinib—TESK1—vagina—uterine fibroid	0.00141	0.00178	CbGeAlD
Crizotinib—IRAK1—mammalian vulva—uterine fibroid	0.00141	0.00178	CbGeAlD
Crizotinib—MAP3K2—uterus—uterine fibroid	0.0014	0.00176	CbGeAlD
Crizotinib—EPHA2—decidua—uterine fibroid	0.0014	0.00176	CbGeAlD
Crizotinib—MAP4K5—smooth muscle tissue—uterine fibroid	0.00139	0.00175	CbGeAlD
Crizotinib—TEK—smooth muscle tissue—uterine fibroid	0.00139	0.00175	CbGeAlD
Crizotinib—BMP2K—female reproductive system—uterine fibroid	0.00139	0.00175	CbGeAlD
Crizotinib—SLK—urethra—uterine fibroid	0.00139	0.00175	CbGeAlD
Crizotinib—RPS6KB1—mammalian vulva—uterine fibroid	0.00138	0.00174	CbGeAlD
Crizotinib—MERTK—female gonad—uterine fibroid	0.00138	0.00174	CbGeAlD
Crizotinib—TBK1—cardiac atrium—uterine fibroid	0.00138	0.00174	CbGeAlD
Crizotinib—FGR—mammalian vulva—uterine fibroid	0.00138	0.00173	CbGeAlD
Crizotinib—LCK—mammalian vulva—uterine fibroid	0.00138	0.00173	CbGeAlD
Crizotinib—EPHB4—urethra—uterine fibroid	0.00138	0.00173	CbGeAlD
Crizotinib—MERTK—vagina—uterine fibroid	0.00137	0.00173	CbGeAlD
Crizotinib—PTK2—uterus—uterine fibroid	0.00137	0.00173	CbGeAlD
Crizotinib—AXL—mammalian vulva—uterine fibroid	0.00137	0.00173	CbGeAlD
Crizotinib—EPHB6—uterine cervix—uterine fibroid	0.00137	0.00173	CbGeAlD
Crizotinib—TYK2—cardiac atrium—uterine fibroid	0.00137	0.00172	CbGeAlD
Crizotinib—JAK2—urethra—uterine fibroid	0.00137	0.00172	CbGeAlD
Crizotinib—TEK—decidua—uterine fibroid	0.00137	0.00172	CbGeAlD
Crizotinib—MAP3K3—decidua—uterine fibroid	0.00137	0.00172	CbGeAlD
Crizotinib—MAP4K5—decidua—uterine fibroid	0.00137	0.00172	CbGeAlD
Crizotinib—SLK—endometrium—uterine fibroid	0.00136	0.00172	CbGeAlD
Crizotinib—TYK2—uterus—uterine fibroid	0.00136	0.00172	CbGeAlD
Crizotinib—EPHB4—endometrium—uterine fibroid	0.00135	0.00171	CbGeAlD
Crizotinib—ABL1—nipple—uterine fibroid	0.00135	0.0017	CbGeAlD
Crizotinib—LIMK2—female gonad—uterine fibroid	0.00135	0.0017	CbGeAlD
Crizotinib—EPHA2—urethra—uterine fibroid	0.00135	0.0017	CbGeAlD
Crizotinib—NUAK2—female gonad—uterine fibroid	0.00135	0.0017	CbGeAlD
Crizotinib—JAK2—endometrium—uterine fibroid	0.00134	0.00169	CbGeAlD
Crizotinib—LIMK2—vagina—uterine fibroid	0.00134	0.00169	CbGeAlD
Crizotinib—NUAK2—vagina—uterine fibroid	0.00134	0.00169	CbGeAlD
Crizotinib—PTK2B—female reproductive system—uterine fibroid	0.00134	0.00169	CbGeAlD
Crizotinib—MAP3K12—female gonad—uterine fibroid	0.00134	0.00168	CbGeAlD
Crizotinib—ACVR1—female gonad—uterine fibroid	0.00134	0.00168	CbGeAlD
Crizotinib—FLT3—female gonad—uterine fibroid	0.00134	0.00168	CbGeAlD
Crizotinib—MAP3K12—vagina—uterine fibroid	0.00133	0.00167	CbGeAlD
Crizotinib—ACVR1—vagina—uterine fibroid	0.00133	0.00167	CbGeAlD
Crizotinib—EPHA2—endometrium—uterine fibroid	0.00133	0.00167	CbGeAlD
Crizotinib—RIPK2—female reproductive system—uterine fibroid	0.00133	0.00167	CbGeAlD
Crizotinib—RPS6KB1—cardiac atrium—uterine fibroid	0.00133	0.00167	CbGeAlD
Crizotinib—YES1—uterine cervix—uterine fibroid	0.00132	0.00167	CbGeAlD
Crizotinib—SLK—mammalian vulva—uterine fibroid	0.00132	0.00166	CbGeAlD
Crizotinib—MAP4K5—urethra—uterine fibroid	0.00132	0.00166	CbGeAlD
Crizotinib—MAP3K3—urethra—uterine fibroid	0.00132	0.00166	CbGeAlD
Crizotinib—TEK—urethra—uterine fibroid	0.00132	0.00166	CbGeAlD
Crizotinib—AXL—cardiac atrium—uterine fibroid	0.00131	0.00165	CbGeAlD
Crizotinib—STK10—uterine cervix—uterine fibroid	0.00131	0.00165	CbGeAlD
Crizotinib—LCK—uterus—uterine fibroid	0.00131	0.00165	CbGeAlD
Crizotinib—STK35—female gonad—uterine fibroid	0.00131	0.00165	CbGeAlD
Crizotinib—EPHB4—mammalian vulva—uterine fibroid	0.00131	0.00165	CbGeAlD
Crizotinib—TAOK3—uterine cervix—uterine fibroid	0.00131	0.00165	CbGeAlD
Crizotinib—AXL—uterus—uterine fibroid	0.00131	0.00164	CbGeAlD
Crizotinib—EPHB6—decidua—uterine fibroid	0.0013	0.00164	CbGeAlD
Crizotinib—STK35—vagina—uterine fibroid	0.0013	0.00164	CbGeAlD
Crizotinib—JAK2—mammalian vulva—uterine fibroid	0.0013	0.00164	CbGeAlD
Crizotinib—MAP3K3—endometrium—uterine fibroid	0.0013	0.00163	CbGeAlD
Crizotinib—TEK—endometrium—uterine fibroid	0.0013	0.00163	CbGeAlD
Crizotinib—MAP4K5—endometrium—uterine fibroid	0.0013	0.00163	CbGeAlD
Crizotinib—YES1—smooth muscle tissue—uterine fibroid	0.00129	0.00162	CbGeAlD
Crizotinib—EPHA2—mammalian vulva—uterine fibroid	0.00129	0.00162	CbGeAlD
Crizotinib—EPHA4—female reproductive system—uterine fibroid	0.00128	0.00162	CbGeAlD
Crizotinib—ABL2—female gonad—uterine fibroid	0.00128	0.00161	CbGeAlD
Crizotinib—SRC—uterine cervix—uterine fibroid	0.00127	0.0016	CbGeAlD
Crizotinib—ABL2—vagina—uterine fibroid	0.00127	0.0016	CbGeAlD
Crizotinib—SLK—cardiac atrium—uterine fibroid	0.00126	0.00159	CbGeAlD
Crizotinib—BMP2K—female gonad—uterine fibroid	0.00126	0.00159	CbGeAlD
Crizotinib—YES1—decidua—uterine fibroid	0.00126	0.00159	CbGeAlD
Crizotinib—MAP3K2—female reproductive system—uterine fibroid	0.00126	0.00159	CbGeAlD
Crizotinib—EPHB6—urethra—uterine fibroid	0.00126	0.00159	CbGeAlD
Crizotinib—SLK—uterus—uterine fibroid	0.00126	0.00158	CbGeAlD
Crizotinib—EPHB4—cardiac atrium—uterine fibroid	0.00125	0.00158	CbGeAlD
Crizotinib—MAP4K5—mammalian vulva—uterine fibroid	0.00125	0.00158	CbGeAlD
Crizotinib—MAP3K3—mammalian vulva—uterine fibroid	0.00125	0.00158	CbGeAlD
Crizotinib—BMP2K—vagina—uterine fibroid	0.00125	0.00158	CbGeAlD
Crizotinib—STK10—decidua—uterine fibroid	0.00125	0.00157	CbGeAlD
Crizotinib—EPHB4—uterus—uterine fibroid	0.00125	0.00157	CbGeAlD
Crizotinib—JAK2—cardiac atrium—uterine fibroid	0.00125	0.00157	CbGeAlD
Crizotinib—TAOK3—decidua—uterine fibroid	0.00124	0.00157	CbGeAlD
Crizotinib—EPHB6—endometrium—uterine fibroid	0.00124	0.00156	CbGeAlD
Crizotinib—SRC—smooth muscle tissue—uterine fibroid	0.00124	0.00156	CbGeAlD
Crizotinib—PTK2—female reproductive system—uterine fibroid	0.00123	0.00155	CbGeAlD
Crizotinib—TBK1—female reproductive system—uterine fibroid	0.00123	0.00155	CbGeAlD
Crizotinib—EPHA2—cardiac atrium—uterine fibroid	0.00123	0.00155	CbGeAlD
Crizotinib—TYK2—female reproductive system—uterine fibroid	0.00122	0.00154	CbGeAlD
Crizotinib—PTK2B—female gonad—uterine fibroid	0.00122	0.00153	CbGeAlD
Crizotinib—YES1—urethra—uterine fibroid	0.00122	0.00153	CbGeAlD
Crizotinib—SRC—decidua—uterine fibroid	0.00121	0.00153	CbGeAlD
Crizotinib—PTK2B—vagina—uterine fibroid	0.00121	0.00153	CbGeAlD
Crizotinib—IRAK1—female reproductive system—uterine fibroid	0.00121	0.00152	CbGeAlD
Crizotinib—RIPK2—female gonad—uterine fibroid	0.00121	0.00152	CbGeAlD
Crizotinib—RIPK2—vagina—uterine fibroid	0.0012	0.00151	CbGeAlD
Crizotinib—TAOK3—urethra—uterine fibroid	0.0012	0.00151	CbGeAlD
Crizotinib—MAP4K5—cardiac atrium—uterine fibroid	0.0012	0.00151	CbGeAlD
Crizotinib—TEK—cardiac atrium—uterine fibroid	0.0012	0.00151	CbGeAlD
Crizotinib—MAP3K3—cardiac atrium—uterine fibroid	0.0012	0.00151	CbGeAlD
Crizotinib—EPHB6—mammalian vulva—uterine fibroid	0.0012	0.00151	CbGeAlD
Crizotinib—YES1—endometrium—uterine fibroid	0.0012	0.00151	CbGeAlD
Crizotinib—MAP4K5—uterus—uterine fibroid	0.00119	0.0015	CbGeAlD
Crizotinib—TEK—uterus—uterine fibroid	0.00119	0.0015	CbGeAlD
Crizotinib—RPS6KB1—female reproductive system—uterine fibroid	0.00119	0.00149	CbGeAlD
Crizotinib—TAOK3—endometrium—uterine fibroid	0.00118	0.00149	CbGeAlD
Crizotinib—FGR—female reproductive system—uterine fibroid	0.00118	0.00148	CbGeAlD
Crizotinib—AXL—female reproductive system—uterine fibroid	0.00117	0.00148	CbGeAlD
Crizotinib—EPHA4—female gonad—uterine fibroid	0.00117	0.00147	CbGeAlD
Crizotinib—ABL1—myometrium—uterine fibroid	0.00116	0.00146	CbGeAlD
Crizotinib—EPHA4—vagina—uterine fibroid	0.00116	0.00146	CbGeAlD
Crizotinib—YES1—mammalian vulva—uterine fibroid	0.00116	0.00146	CbGeAlD
Crizotinib—STK10—mammalian vulva—uterine fibroid	0.00115	0.00145	CbGeAlD
Crizotinib—EPHB6—cardiac atrium—uterine fibroid	0.00115	0.00145	CbGeAlD
Crizotinib—MAP3K2—female gonad—uterine fibroid	0.00115	0.00144	CbGeAlD
Crizotinib—TAOK3—mammalian vulva—uterine fibroid	0.00114	0.00144	CbGeAlD
Crizotinib—CSF1R—uterine cervix—uterine fibroid	0.00114	0.00144	CbGeAlD
Crizotinib—EPHB4—female reproductive system—uterine fibroid	0.00112	0.00141	CbGeAlD
Crizotinib—PTK2—female gonad—uterine fibroid	0.00112	0.00141	CbGeAlD
Crizotinib—TBK1—female gonad—uterine fibroid	0.00112	0.00141	CbGeAlD
Crizotinib—TBK1—vagina—uterine fibroid	0.00111	0.0014	CbGeAlD
Crizotinib—PTK2—vagina—uterine fibroid	0.00111	0.0014	CbGeAlD
Crizotinib—TYK2—female gonad—uterine fibroid	0.00111	0.0014	CbGeAlD
Crizotinib—JAK2—female reproductive system—uterine fibroid	0.00111	0.0014	CbGeAlD
Crizotinib—CSF1R—smooth muscle tissue—uterine fibroid	0.00111	0.0014	CbGeAlD
Crizotinib—YES1—cardiac atrium—uterine fibroid	0.00111	0.0014	CbGeAlD
Crizotinib—TYK2—vagina—uterine fibroid	0.00111	0.00139	CbGeAlD
Crizotinib—YES1—uterus—uterine fibroid	0.0011	0.00139	CbGeAlD
Crizotinib—EPHA5—Developmental Biology—MED12—uterine fibroid	0.0011	0.00535	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—MED12—uterine fibroid	0.0011	0.00535	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—MED12—uterine fibroid	0.0011	0.00535	CbGpPWpGaD
Crizotinib—TYK2—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.0011	0.00535	CbGpPWpGaD
Crizotinib—EPHA2—female reproductive system—uterine fibroid	0.0011	0.00139	CbGeAlD
Crizotinib—IRAK1—female gonad—uterine fibroid	0.0011	0.00139	CbGeAlD
Crizotinib—AURKA—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.0011	0.00533	CbGpPWpGaD
Crizotinib—TAOK3—cardiac atrium—uterine fibroid	0.00109	0.00138	CbGeAlD
Crizotinib—STK10—uterus—uterine fibroid	0.00109	0.00138	CbGeAlD
Crizotinib—CSF1R—decidua—uterine fibroid	0.00109	0.00137	CbGeAlD
Crizotinib—TAOK3—uterus—uterine fibroid	0.00109	0.00137	CbGeAlD
Crizotinib—RPS6KB1—female gonad—uterine fibroid	0.00108	0.00136	CbGeAlD
Crizotinib—NTRK1—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00108	0.00523	CbGpPWpGaD
Crizotinib—MAP3K3—female reproductive system—uterine fibroid	0.00107	0.00135	CbGeAlD
Crizotinib—TEK—female reproductive system—uterine fibroid	0.00107	0.00135	CbGeAlD
Crizotinib—MAP4K5—female reproductive system—uterine fibroid	0.00107	0.00135	CbGeAlD
Crizotinib—RPS6KB1—vagina—uterine fibroid	0.00107	0.00135	CbGeAlD
Crizotinib—LCK—female gonad—uterine fibroid	0.00107	0.00135	CbGeAlD
Crizotinib—FGR—female gonad—uterine fibroid	0.00107	0.00135	CbGeAlD
Crizotinib—AXL—female gonad—uterine fibroid	0.00107	0.00135	CbGeAlD
Crizotinib—SRC—cardiac atrium—uterine fibroid	0.00107	0.00134	CbGeAlD
Crizotinib—YES1—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00107	0.00517	CbGpPWpGaD
Crizotinib—LCK—vagina—uterine fibroid	0.00107	0.00134	CbGeAlD
Crizotinib—FGR—vagina—uterine fibroid	0.00107	0.00134	CbGeAlD
Crizotinib—EPHA8—Developmental Biology—MED12—uterine fibroid	0.00106	0.00516	CbGpPWpGaD
Crizotinib—PTK2—Leptin signaling pathway—ESR1—uterine fibroid	0.00106	0.00516	CbGpPWpGaD
Crizotinib—AXL—vagina—uterine fibroid	0.00106	0.00134	CbGeAlD
Crizotinib—TYK2—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00105	0.00512	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—MED12—uterine fibroid	0.00105	0.00511	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—MED12—uterine fibroid	0.00105	0.00511	CbGpPWpGaD
Crizotinib—EPHB4—Developmental Biology—MED12—uterine fibroid	0.00105	0.00511	CbGpPWpGaD
Crizotinib—CSF1R—urethra—uterine fibroid	0.00105	0.00132	CbGeAlD
Crizotinib—TYK2—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00104	0.00504	CbGpPWpGaD
Crizotinib—CSF1R—endometrium—uterine fibroid	0.00103	0.0013	CbGeAlD
Crizotinib—LIMK1—Developmental Biology—MED12—uterine fibroid	0.00103	0.005	CbGpPWpGaD
Crizotinib—SLK—female gonad—uterine fibroid	0.00103	0.0013	CbGeAlD
Crizotinib—TYK2—Signaling by ERBB4—PGR—uterine fibroid	0.00103	0.00499	CbGpPWpGaD
Crizotinib—SLK—vagina—uterine fibroid	0.00102	0.00129	CbGeAlD
Crizotinib—EPHB4—female gonad—uterine fibroid	0.00102	0.00129	CbGeAlD
Crizotinib—EPHB4—vagina—uterine fibroid	0.00101	0.00128	CbGeAlD
Crizotinib—JAK2—female gonad—uterine fibroid	0.00101	0.00128	CbGeAlD
Crizotinib—JAK2—vagina—uterine fibroid	0.00101	0.00127	CbGeAlD
Crizotinib—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00101	0.00488	CbGpPWpGaD
Crizotinib—EPHA2—female gonad—uterine fibroid	0.001	0.00126	CbGeAlD
Crizotinib—CSF1R—mammalian vulva—uterine fibroid	0.001	0.00126	CbGeAlD
Crizotinib—EPHA2—vagina—uterine fibroid	0.000995	0.00125	CbGeAlD
Crizotinib—CYP3A5—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000993	0.00482	CbGpPWpGaD
Crizotinib—YES1—female reproductive system—uterine fibroid	0.000992	0.00125	CbGeAlD
Crizotinib—TYK2—Downstream signal transduction—TNRC6B—uterine fibroid	0.000991	0.00481	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—MED12—uterine fibroid	0.000989	0.0048	CbGpPWpGaD
Crizotinib—TYK2—Signaling by FGFR—TNRC6B—uterine fibroid	0.000987	0.00479	CbGpPWpGaD
Crizotinib—STK10—female reproductive system—uterine fibroid	0.000983	0.00124	CbGeAlD
Crizotinib—TYK2—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000982	0.00476	CbGpPWpGaD
Crizotinib—LCK—PI-3K cascade—TNRC6B—uterine fibroid	0.000979	0.00475	CbGpPWpGaD
Crizotinib—TAOK3—female reproductive system—uterine fibroid	0.000979	0.00123	CbGeAlD
Crizotinib—TEK—female gonad—uterine fibroid	0.000977	0.00123	CbGeAlD
Crizotinib—MAP3K3—female gonad—uterine fibroid	0.000977	0.00123	CbGeAlD
Crizotinib—MAP4K5—female gonad—uterine fibroid	0.000977	0.00123	CbGeAlD
Crizotinib—TYK2—DAP12 signaling—TNRC6B—uterine fibroid	0.000977	0.00474	CbGpPWpGaD
Crizotinib—MAPK7—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000974	0.00473	CbGpPWpGaD
Crizotinib—MAP4K5—vagina—uterine fibroid	0.000971	0.00122	CbGeAlD
Crizotinib—MAP3K3—vagina—uterine fibroid	0.000971	0.00122	CbGeAlD
Crizotinib—CSF1R—cardiac atrium—uterine fibroid	0.000958	0.00121	CbGeAlD
Crizotinib—LCK—PI3K/AKT activation—TNRC6B—uterine fibroid	0.000956	0.00464	CbGpPWpGaD
Crizotinib—SRC—female reproductive system—uterine fibroid	0.000954	0.0012	CbGeAlD
Crizotinib—CSF1R—uterus—uterine fibroid	0.000953	0.0012	CbGeAlD
Crizotinib—LCK—GAB1 signalosome—TNRC6B—uterine fibroid	0.000948	0.0046	CbGpPWpGaD
Crizotinib—EPHB6—female gonad—uterine fibroid	0.000934	0.00118	CbGeAlD
Crizotinib—EPHA6—Developmental Biology—MED12—uterine fibroid	0.00093	0.00451	CbGpPWpGaD
Crizotinib—EPHB6—vagina—uterine fibroid	0.000928	0.00117	CbGeAlD
Crizotinib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.000926	0.0045	CbGpPWpGaD
Crizotinib—SRC—Plasma membrane estrogen receptor signaling—ESR1—uterine fibroid	0.00092	0.00446	CbGpPWpGaD
Crizotinib—TYK2—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000919	0.00446	CbGpPWpGaD
Crizotinib—TYK2—DAP12 interactions—TNRC6B—uterine fibroid	0.000919	0.00446	CbGpPWpGaD
Crizotinib—TYK2—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000919	0.00446	CbGpPWpGaD
Crizotinib—TYK2—Signaling by EGFR—TNRC6B—uterine fibroid	0.000911	0.00442	CbGpPWpGaD
Crizotinib—ABL1—uterine cervix—uterine fibroid	0.000904	0.00114	CbGeAlD
Crizotinib—TYK2—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000903	0.00438	CbGpPWpGaD
Crizotinib—YES1—female gonad—uterine fibroid	0.000902	0.00114	CbGeAlD
Crizotinib—TYK2—Signaling by PDGF—TNRC6B—uterine fibroid	0.000899	0.00436	CbGpPWpGaD
Crizotinib—YES1—vagina—uterine fibroid	0.000897	0.00113	CbGeAlD
Crizotinib—STK10—female gonad—uterine fibroid	0.000894	0.00113	CbGeAlD
Crizotinib—LYN—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.000893	0.00433	CbGpPWpGaD
Crizotinib—TAOK3—female gonad—uterine fibroid	0.000891	0.00112	CbGeAlD
Crizotinib—STK10—vagina—uterine fibroid	0.000889	0.00112	CbGeAlD
Crizotinib—TAOK3—vagina—uterine fibroid	0.000885	0.00112	CbGeAlD
Crizotinib—RIPK2—Signaling by NGF—TNRC6B—uterine fibroid	0.000879	0.00426	CbGpPWpGaD
Crizotinib—ABL1—smooth muscle tissue—uterine fibroid	0.000878	0.00111	CbGeAlD
Crizotinib—SRC—female gonad—uterine fibroid	0.000868	0.00109	CbGeAlD
Crizotinib—ABL1—decidua—uterine fibroid	0.000861	0.00108	CbGeAlD
Crizotinib—EPHA2—Developmental Biology—MED12—uterine fibroid	0.000858	0.00416	CbGpPWpGaD
Crizotinib—CSF1R—female reproductive system—uterine fibroid	0.000856	0.00108	CbGeAlD
Crizotinib—ABL1—Regulation of Telomerase—ESR1—uterine fibroid	0.000842	0.00409	CbGpPWpGaD
Crizotinib—SRC—GAB1 signalosome—TNRC6B—uterine fibroid	0.000839	0.00407	CbGpPWpGaD
Crizotinib—SRC—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000839	0.00407	CbGpPWpGaD
Crizotinib—IKBKE—Innate Immune System—TNRC6B—uterine fibroid	0.000837	0.00406	CbGpPWpGaD
Crizotinib—JAK2—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.000835	0.00405	CbGpPWpGaD
Crizotinib—ABL1—urethra—uterine fibroid	0.00083	0.00105	CbGeAlD
Crizotinib—NTRK1—Signaling by NGF—TNRC6B—uterine fibroid	0.000829	0.00402	CbGpPWpGaD
Crizotinib—ABL1—endometrium—uterine fibroid	0.000817	0.00103	CbGeAlD
Crizotinib—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000816	0.00396	CbGpPWpGaD
Crizotinib—TYK2—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000814	0.00395	CbGpPWpGaD
Crizotinib—CDK7—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000812	0.00394	CbGpPWpGaD
Crizotinib—JAK2—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.000799	0.00388	CbGpPWpGaD
Crizotinib—ABL1—mammalian vulva—uterine fibroid	0.000791	0.000996	CbGeAlD
Crizotinib—CDK7—Disease—HPSE2—uterine fibroid	0.000788	0.00383	CbGpPWpGaD
Crizotinib—JAK2—Signaling by ERBB4—TNRC6B—uterine fibroid	0.000787	0.00382	CbGpPWpGaD
Crizotinib—CSF1R—female gonad—uterine fibroid	0.000779	0.000982	CbGeAlD
Crizotinib—JAK2—Signaling by ERBB4—PGR—uterine fibroid	0.000779	0.00378	CbGpPWpGaD
Crizotinib—CSF1R—vagina—uterine fibroid	0.000775	0.000976	CbGeAlD
Crizotinib—MAPK7—Innate Immune System—TNRC6B—uterine fibroid	0.000761	0.00369	CbGpPWpGaD
Crizotinib—LIMK1—Innate Immune System—TNRC6B—uterine fibroid	0.000761	0.00369	CbGpPWpGaD
Crizotinib—ABL1—cardiac atrium—uterine fibroid	0.000757	0.000953	CbGeAlD
Crizotinib—ABL1—uterus—uterine fibroid	0.000753	0.000949	CbGeAlD
Crizotinib—JAK2—Downstream signal transduction—TNRC6B—uterine fibroid	0.000751	0.00365	CbGpPWpGaD
Crizotinib—JAK2—Signaling by FGFR—TNRC6B—uterine fibroid	0.000748	0.00363	CbGpPWpGaD
Crizotinib—LYN—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000744	0.00361	CbGpPWpGaD
Crizotinib—JAK2—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000744	0.00361	CbGpPWpGaD
Crizotinib—JAK2—DAP12 signaling—TNRC6B—uterine fibroid	0.00074	0.00359	CbGpPWpGaD
Crizotinib—LCK—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.000732	0.00355	CbGpPWpGaD
Crizotinib—JAK2—Leptin signaling pathway—ESR1—uterine fibroid	0.000732	0.00355	CbGpPWpGaD
Crizotinib—LCK—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.0007	0.0034	CbGpPWpGaD
Crizotinib—JAK2—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000697	0.00338	CbGpPWpGaD
Crizotinib—JAK2—DAP12 interactions—TNRC6B—uterine fibroid	0.000697	0.00338	CbGpPWpGaD
Crizotinib—JAK2—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000697	0.00338	CbGpPWpGaD
Crizotinib—JAK2—Signaling by EGFR—TNRC6B—uterine fibroid	0.00069	0.00335	CbGpPWpGaD
Crizotinib—LCK—Signaling by ERBB4—TNRC6B—uterine fibroid	0.000689	0.00334	CbGpPWpGaD
Crizotinib—LYN—B Cell Activation—TNRC6B—uterine fibroid	0.000689	0.00334	CbGpPWpGaD
Crizotinib—JAK2—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000684	0.00332	CbGpPWpGaD
Crizotinib—LCK—Signaling by ERBB4—PGR—uterine fibroid	0.000682	0.00331	CbGpPWpGaD
Crizotinib—JAK2—Signaling by PDGF—TNRC6B—uterine fibroid	0.000681	0.00331	CbGpPWpGaD
Crizotinib—ABL1—female reproductive system—uterine fibroid	0.000677	0.000853	CbGeAlD
Crizotinib—LCK—Downstream signal transduction—TNRC6B—uterine fibroid	0.000658	0.00319	CbGpPWpGaD
Crizotinib—LCK—Signaling by FGFR—TNRC6B—uterine fibroid	0.000655	0.00318	CbGpPWpGaD
Crizotinib—LCK—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000652	0.00316	CbGpPWpGaD
Crizotinib—LCK—DAP12 signaling—TNRC6B—uterine fibroid	0.000648	0.00315	CbGpPWpGaD
Crizotinib—SRC—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.000648	0.00314	CbGpPWpGaD
Crizotinib—IRAK1—Signaling by NGF—TNRC6B—uterine fibroid	0.000645	0.00313	CbGpPWpGaD
Crizotinib—TXK—Immune System—TNRC6B—uterine fibroid	0.000643	0.00312	CbGpPWpGaD
Crizotinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.000639	0.0031	CbGpPWpGaD
Crizotinib—TYK2—Signaling by NGF—TNRC6B—uterine fibroid	0.000626	0.00304	CbGpPWpGaD
Crizotinib—TBK1—Innate Immune System—TNRC6B—uterine fibroid	0.000622	0.00302	CbGpPWpGaD
Crizotinib—JAK2—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000617	0.00299	CbGpPWpGaD
Crizotinib—ABL1—female gonad—uterine fibroid	0.000616	0.000776	CbGeAlD
Crizotinib—ABL1—vagina—uterine fibroid	0.000612	0.000771	CbGeAlD
Crizotinib—PRKD1—Metabolism—MED12—uterine fibroid	0.000611	0.00296	CbGpPWpGaD
Crizotinib—LCK—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00061	0.00296	CbGpPWpGaD
Crizotinib—LCK—DAP12 interactions—TNRC6B—uterine fibroid	0.00061	0.00296	CbGpPWpGaD
Crizotinib—LCK—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00061	0.00296	CbGpPWpGaD
Crizotinib—NTRK1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000605	0.00294	CbGpPWpGaD
Crizotinib—LCK—Signaling by EGFR—TNRC6B—uterine fibroid	0.000605	0.00293	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—TNRC6B—uterine fibroid	0.0006	0.00291	CbGpPWpGaD
Crizotinib—LCK—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000599	0.00291	CbGpPWpGaD
Crizotinib—LCK—Signaling by PDGF—TNRC6B—uterine fibroid	0.000597	0.0029	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—PGR—uterine fibroid	0.000594	0.00288	CbGpPWpGaD
Crizotinib—SRC—Downstream signal transduction—TNRC6B—uterine fibroid	0.000583	0.00283	CbGpPWpGaD
Crizotinib—SRC—Signaling by FGFR—TNRC6B—uterine fibroid	0.00058	0.00281	CbGpPWpGaD
Crizotinib—SRC—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000577	0.0028	CbGpPWpGaD
Crizotinib—SRC—Leptin signaling pathway—ESR1—uterine fibroid	0.000567	0.00275	CbGpPWpGaD
Crizotinib—LCK—B Cell Activation—TNRC6B—uterine fibroid	0.000565	0.00274	CbGpPWpGaD
Crizotinib—TYK2—Signaling by ERBB4—ESR1—uterine fibroid	0.000549	0.00266	CbGpPWpGaD
Crizotinib—LCK—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00054	0.00262	CbGpPWpGaD
Crizotinib—SRC—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00054	0.00262	CbGpPWpGaD
Crizotinib—TYK2—Disease—HPSE2—uterine fibroid	0.000536	0.0026	CbGpPWpGaD
Crizotinib—SRC—Signaling by EGFR—TNRC6B—uterine fibroid	0.000535	0.0026	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—MED12—uterine fibroid	0.000532	0.00258	CbGpPWpGaD
Crizotinib—SRC—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000531	0.00257	CbGpPWpGaD
Crizotinib—CYP3A5—uterine cervix—uterine fibroid	0.000529	0.000666	CbGeAlD
Crizotinib—SRC—Signaling by PDGF—TNRC6B—uterine fibroid	0.000528	0.00256	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—MED12—uterine fibroid	0.000525	0.00255	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—CYP17A1—uterine fibroid	0.000511	0.00248	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—TNRC6B—uterine fibroid	0.00051	0.00247	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—PGR—uterine fibroid	0.000505	0.00245	CbGpPWpGaD
Crizotinib—RIPK2—Innate Immune System—TNRC6B—uterine fibroid	0.000501	0.00243	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—TNRC6B—uterine fibroid	0.000487	0.00236	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—MED12—uterine fibroid	0.000483	0.00234	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—TNRC6B—uterine fibroid	0.000481	0.00234	CbGpPWpGaD
Crizotinib—FGR—Innate Immune System—TNRC6B—uterine fibroid	0.00048	0.00233	CbGpPWpGaD
Crizotinib—SRC—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000478	0.00232	CbGpPWpGaD
Crizotinib—JAK2—Signaling by NGF—TNRC6B—uterine fibroid	0.000474	0.0023	CbGpPWpGaD
Crizotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000468	0.00227	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—TNRC6B—uterine fibroid	0.000463	0.00225	CbGpPWpGaD
Crizotinib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000462	0.00224	CbGpPWpGaD
Crizotinib—ABL1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000445	0.00216	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—TNRC6B—uterine fibroid	0.000443	0.00215	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—TNRC6B—uterine fibroid	0.000443	0.00215	CbGpPWpGaD
Crizotinib—CYP3A5—Biological oxidations—CYP17A1—uterine fibroid	0.000433	0.0021	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—TNRC6B—uterine fibroid	0.000427	0.00207	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—TNRC6B—uterine fibroid	0.000427	0.00207	CbGpPWpGaD
Crizotinib—CYP3A5—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000427	0.00207	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—PGR—uterine fibroid	0.000423	0.00205	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—PGR—uterine fibroid	0.000423	0.00205	CbGpPWpGaD
Crizotinib—JAK2—Signaling by ERBB4—ESR1—uterine fibroid	0.000416	0.00202	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—TNRC6B—uterine fibroid	0.000416	0.00202	CbGpPWpGaD
Crizotinib—JAK2—Disease—HPSE2—uterine fibroid	0.000406	0.00197	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—TNRC6B—uterine fibroid	0.000405	0.00197	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—PGR—uterine fibroid	0.000401	0.00195	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—TNRC6B—uterine fibroid	0.000393	0.00191	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—MED12—uterine fibroid	0.000391	0.0019	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—MED12—uterine fibroid	0.000389	0.00189	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—TNRC6B—uterine fibroid	0.000388	0.00188	CbGpPWpGaD
Crizotinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000379	0.00184	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—TNRC6B—uterine fibroid	0.000372	0.00181	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—TNRC6B—uterine fibroid	0.00037	0.0018	CbGpPWpGaD
Crizotinib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000368	0.00179	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—TNRC6B—uterine fibroid	0.000368	0.00179	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—TNRC6B—uterine fibroid	0.000368	0.00179	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—PGR—uterine fibroid	0.000367	0.00178	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—MED12—uterine fibroid	0.000366	0.00178	CbGpPWpGaD
Crizotinib—LCK—Signaling by ERBB4—ESR1—uterine fibroid	0.000364	0.00177	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—MED12—uterine fibroid	0.000363	0.00176	CbGpPWpGaD
Crizotinib—TBK1—Immune System—TNRC6B—uterine fibroid	0.000362	0.00176	CbGpPWpGaD
Crizotinib—ABCB1—myometrium—uterine fibroid	0.000361	0.000455	CbGeAlD
Crizotinib—CYP3A5—female gonad—uterine fibroid	0.000361	0.000454	CbGeAlD
Crizotinib—CYP3A5—vagina—uterine fibroid	0.000358	0.000451	CbGeAlD
Crizotinib—TYK2—Innate Immune System—TNRC6B—uterine fibroid	0.000357	0.00173	CbGpPWpGaD
Crizotinib—LCK—Disease—HPSE2—uterine fibroid	0.000356	0.00173	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—TNRC6B—uterine fibroid	0.000347	0.00169	CbGpPWpGaD
Crizotinib—JAK3—Immune System—TNRC6B—uterine fibroid	0.000327	0.00159	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TNRC6B—uterine fibroid	0.000324	0.00157	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—PGR—uterine fibroid	0.000321	0.00156	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—ESR1—uterine fibroid	0.000317	0.00154	CbGpPWpGaD
Crizotinib—SRC—Disease—HPSE2—uterine fibroid	0.000315	0.00153	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—TNRC6B—uterine fibroid	0.000304	0.00148	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—PGR—uterine fibroid	0.000301	0.00146	CbGpPWpGaD
Crizotinib—CYP3A4—female reproductive system—uterine fibroid	0.000297	0.000375	CbGeAlD
Crizotinib—IGF1R—Signaling Pathways—TNRC6B—uterine fibroid	0.000293	0.00142	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—TNRC6B—uterine fibroid	0.000292	0.00142	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—PGR—uterine fibroid	0.00029	0.00141	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—TNRC6B—uterine fibroid	0.000289	0.0014	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—TNRC6B—uterine fibroid	0.000288	0.0014	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—TNRC6B—uterine fibroid	0.000288	0.0014	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TNRC6B—uterine fibroid	0.000287	0.00139	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MED12—uterine fibroid	0.000284	0.00138	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—PGR—uterine fibroid	0.000284	0.00138	CbGpPWpGaD
Crizotinib—CDK7—Disease—TNRC6B—uterine fibroid	0.000282	0.00137	CbGpPWpGaD
Crizotinib—ABCB1—uterine cervix—uterine fibroid	0.000281	0.000354	CbGeAlD
Crizotinib—BLK—Immune System—TNRC6B—uterine fibroid	0.000281	0.00136	CbGpPWpGaD
Crizotinib—FGR—Immune System—TNRC6B—uterine fibroid	0.00028	0.00136	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—TNRC6B—uterine fibroid	0.000278	0.00135	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—TNRC6B—uterine fibroid	0.000271	0.00131	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—ESR1—uterine fibroid	0.00027	0.00131	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000269	0.0013	CbGpPWpGaD
Crizotinib—ABCB1—decidua—uterine fibroid	0.000268	0.000337	CbGeAlD
Crizotinib—ABCB1—urethra—uterine fibroid	0.000258	0.000325	CbGeAlD
Crizotinib—ABCB1—endometrium—uterine fibroid	0.000254	0.00032	CbGeAlD
Crizotinib—ABCB1—mammalian vulva—uterine fibroid	0.000246	0.00031	CbGeAlD
Crizotinib—LCK—Innate Immune System—TNRC6B—uterine fibroid	0.000237	0.00115	CbGpPWpGaD
Crizotinib—ABCB1—uterus—uterine fibroid	0.000234	0.000295	CbGeAlD
Crizotinib—PTK2—Immune System—TNRC6B—uterine fibroid	0.000229	0.00111	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—TNRC6B—uterine fibroid	0.000228	0.0011	CbGpPWpGaD
Crizotinib—YES1—Immune System—TNRC6B—uterine fibroid	0.000226	0.0011	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—ESR1—uterine fibroid	0.000226	0.0011	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—ESR1—uterine fibroid	0.000226	0.0011	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—TNRC6B—uterine fibroid	0.000214	0.00104	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—ESR1—uterine fibroid	0.000214	0.00104	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TNRC6B—uterine fibroid	0.000212	0.00103	CbGpPWpGaD
Crizotinib—ABCB1—female reproductive system—uterine fibroid	0.000211	0.000265	CbGeAlD
Crizotinib—SRC—Innate Immune System—TNRC6B—uterine fibroid	0.00021	0.00102	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—PGR—uterine fibroid	0.00021	0.00102	CbGpPWpGaD
Crizotinib—TYK2—Immune System—TNRC6B—uterine fibroid	0.000208	0.00101	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—HPSE2—uterine fibroid	0.000207	0.001	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—TNRC6B—uterine fibroid	0.000202	0.000978	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.000201	0.000978	CbGpPWpGaD
Crizotinib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000199	0.000964	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—ESR1—uterine fibroid	0.000196	0.00095	CbGpPWpGaD
Crizotinib—TYK2—Disease—TNRC6B—uterine fibroid	0.000192	0.000932	CbGpPWpGaD
Crizotinib—ABCB1—female gonad—uterine fibroid	0.000192	0.000241	CbGeAlD
Crizotinib—ABCB1—vagina—uterine fibroid	0.00019	0.00024	CbGeAlD
Crizotinib—RIPK2—Signaling Pathways—TNRC6B—uterine fibroid	0.000189	0.000916	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—PGR—uterine fibroid	0.000187	0.000907	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TNRC6B—uterine fibroid	0.000186	0.000903	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—PGR—uterine fibroid	0.000184	0.000894	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TNRC6B—uterine fibroid	0.000178	0.000864	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—PGR—uterine fibroid	0.000176	0.000855	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TNRC6B—uterine fibroid	0.000173	0.000838	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—ESR1—uterine fibroid	0.000171	0.000831	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—PGR—uterine fibroid	0.000171	0.000829	CbGpPWpGaD
Crizotinib—LYN—Immune System—TNRC6B—uterine fibroid	0.000168	0.000817	CbGpPWpGaD
Crizotinib—ABL1—Immune System—TNRC6B—uterine fibroid	0.000168	0.000814	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—ESR1—uterine fibroid	0.000161	0.000781	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000159	0.000771	CbGpPWpGaD
Crizotinib—JAK2—Immune System—TNRC6B—uterine fibroid	0.000158	0.000765	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HPSE2—uterine fibroid	0.000156	0.000757	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—ESR1—uterine fibroid	0.000155	0.000751	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—ESR1—uterine fibroid	0.000151	0.000735	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TNRC6B—uterine fibroid	0.000148	0.000719	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PGR—uterine fibroid	0.000147	0.000711	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TNRC6B—uterine fibroid	0.000146	0.000709	CbGpPWpGaD
Crizotinib—JAK2—Disease—TNRC6B—uterine fibroid	0.000146	0.000706	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PGR—uterine fibroid	0.000145	0.000702	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TNRC6B—uterine fibroid	0.000139	0.000672	CbGpPWpGaD
Crizotinib—LCK—Immune System—TNRC6B—uterine fibroid	0.000138	0.00067	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PGR—uterine fibroid	0.000137	0.000666	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TNRC6B—uterine fibroid	0.000134	0.000653	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PGR—uterine fibroid	0.000133	0.000646	CbGpPWpGaD
Crizotinib—LCK—Disease—TNRC6B—uterine fibroid	0.000127	0.000619	CbGpPWpGaD
Crizotinib—SRC—Immune System—TNRC6B—uterine fibroid	0.000122	0.000593	CbGpPWpGaD
Crizotinib—SRC—Disease—TNRC6B—uterine fibroid	0.000113	0.000548	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—ESR1—uterine fibroid	0.000112	0.000543	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TNRC6B—uterine fibroid	0.000109	0.000529	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PGR—uterine fibroid	0.000108	0.000523	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TNRC6B—uterine fibroid	0.000102	0.000495	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PGR—uterine fibroid	0.000101	0.00049	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—ESR1—uterine fibroid	9.98e-05	0.000484	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—ESR1—uterine fibroid	9.83e-05	0.000477	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HPSE2—uterine fibroid	9.61e-05	0.000466	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—ESR1—uterine fibroid	9.41e-05	0.000457	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—ESR1—uterine fibroid	9.12e-05	0.000443	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TNRC6B—uterine fibroid	8.93e-05	0.000433	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MED12—uterine fibroid	8.85e-05	0.00043	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PGR—uterine fibroid	8.84e-05	0.000429	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TNRC6B—uterine fibroid	7.9e-05	0.000384	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—ESR1—uterine fibroid	7.83e-05	0.00038	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PGR—uterine fibroid	7.82e-05	0.00038	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—ESR1—uterine fibroid	7.72e-05	0.000375	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP17A1—uterine fibroid	7.41e-05	0.00036	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—ESR1—uterine fibroid	7.32e-05	0.000355	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—ESR1—uterine fibroid	7.11e-05	0.000345	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MED12—uterine fibroid	6.68e-05	0.000324	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—ESR1—uterine fibroid	5.76e-05	0.000279	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP17A1—uterine fibroid	5.59e-05	0.000271	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ESR1—uterine fibroid	5.39e-05	0.000261	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ESR1—uterine fibroid	4.72e-05	0.000229	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ESR1—uterine fibroid	4.18e-05	0.000203	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MED12—uterine fibroid	4.12e-05	0.0002	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	3.44e-05	0.000167	CbGpPWpGaD
